Aclaris Therapeutics Stock Price on December 7, 2021
| ACRS Stock | USD 1.22 0.02 1.61% |
Below is the normalized historical share price chart for Aclaris Therapeutics extending back to October 07, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Aclaris Therapeutics stands at 1.22, as last reported on the 23rd of April, with the highest price reaching 1.25 and the lowest price hitting 1.21 during the day.
If you're considering investing in Aclaris Stock, it is important to understand the factors that can impact its price. We consider Aclaris Therapeutics slightly risky. Aclaris Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0052, which signifies that the company had a 0.0052% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Aclaris Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Aclaris Therapeutics' Mean Deviation of 2.75, downside deviation of 3.88, and Risk Adjusted Performance of 0.0318 to double-check if the risk estimate we provide is consistent with the expected return of 0.0203%.
At this time, Aclaris Therapeutics' Common Stock Total Equity is comparatively stable compared to the past year. Common Stock is likely to gain to 1,208 in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 38.5 M in 2024. . At this time, Aclaris Therapeutics' Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.13 in 2024, whereas Price Earnings Ratio is likely to drop (0.87) in 2024. Aclaris Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 7th of October 2015 | 200 Day MA 4.0019 | 50 Day MA 1.2204 | Beta 0.228 |
Aclaris |
Sharpe Ratio = 0.0052
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ACRS |
Estimated Market Risk
| 3.86 actual daily | 34 66% of assets are more volatile |
Expected Return
| 0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Aclaris Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aclaris Therapeutics by adding Aclaris Therapeutics to a well-diversified portfolio.
Price Book 0.546 | Enterprise Value Ebitda 0.2846 | Price Sales 2.7463 | Shares Float 50.4 M | Wall Street Target Price 1.8 |
Aclaris Therapeutics Valuation on December 7, 2021
It is possible to determine the worth of Aclaris Therapeutics on a given historical date. On December 7, 2021 Aclaris was worth 17.07 at the beginning of the trading date compared to the closed value of 16.18. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Aclaris Therapeutics stock. Still, in general, we apply an absolute valuation method to find Aclaris Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aclaris Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Aclaris Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
04/07/2022 | 17.07 | 17.08 | 16.14 | 16.18 | 225,400 |
| 16.12 | 16.31 | 15.01 | 15.41 | 445,200 |
| Backtest Aclaris Therapeutics | | | Aclaris Therapeutics History | | | Aclaris Therapeutics Valuation | Next |
Aclaris Therapeutics Trading Date Momentum on December 7, 2021
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Aclaris Therapeutics Fundamentals Correlations and Trends
By evaluating Aclaris Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Aclaris Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Aclaris financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Aclaris Therapeutics Stock history
Aclaris Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aclaris is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aclaris Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aclaris Therapeutics stock prices may prove useful in developing a viable investing in Aclaris Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 69.8 M | 38.5 M | |
| Net Loss | -78.2 M | -82.1 M |
Aclaris Therapeutics Quarterly Net Working Capital |
|
Aclaris Therapeutics Stock Technical Analysis
Aclaris Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Aclaris Therapeutics Period Price Range
Low | April 7, 2022
| High |
17.07 | 16.18 |
Aclaris Therapeutics April 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Aclaris Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aclaris Therapeutics shares will generate the highest return on investment. By undertsting and applying Aclaris Therapeutics stock market strength indicators, traders can identify Aclaris Therapeutics entry and exit signals to maximize returns
| Accumulation Distribution | 12404.92 | |||
| Daily Balance Of Power | (0.95) | |||
| Rate Of Daily Change | 0.95 | |||
| Day Median Price | 16.61 | |||
| Day Typical Price | 16.47 | |||
| Price Action Indicator | (0.87) | |||
| Period Momentum Indicator | (14.96) |
Aclaris Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aclaris Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Aclaris Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aclaris to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0318 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.35) | |||
| Sortino Ratio | 0.0171 | |||
| Treynor Ratio | 0.072 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aclaris Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Aclaris Stock please use our How to Invest in Aclaris Therapeutics guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Aclaris Stock analysis
When running Aclaris Therapeutics' price analysis, check to measure Aclaris Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aclaris Therapeutics is operating at the current time. Most of Aclaris Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aclaris Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aclaris Therapeutics' price. Additionally, you may evaluate how the addition of Aclaris Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is Aclaris Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aclaris Therapeutics. If investors know Aclaris will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aclaris Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.27) | Revenue Per Share 0.448 | Quarterly Revenue Growth 1.266 | Return On Assets (0.33) | Return On Equity (0.50) |
The market value of Aclaris Therapeutics is measured differently than its book value, which is the value of Aclaris that is recorded on the company's balance sheet. Investors also form their own opinion of Aclaris Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aclaris Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aclaris Therapeutics' market value can be influenced by many factors that don't directly affect Aclaris Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aclaris Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aclaris Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aclaris Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.